Pathology

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

P
PhilipsNetherlands - Amsterdam
2 programs
Instrument Precision Study for Validation of Philips DxN/A1 trial
PIPS 5.1N/A1 trial
Active Trials
NCT02699970Completed399Est. Oct 2016
NCT04879056Unknown399Est. Sep 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PhilipsPIPS 5.1
PhilipsInstrument Precision Study for Validation of Philips Dx

Clinical Trials (2)

Total enrollment: 798 patients across 2 trials

Instrument Precision Study for Validation of PIPS 5.1

Start: May 2021Est. completion: Sep 2022399 patients
N/AUnknown
NCT02699970PhilipsInstrument Precision Study for Validation of Philips Dx

Instrument Precision Study for Validation of Philips Dx

Start: Feb 2016Est. completion: Oct 2016399 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space